scholarly article | Q13442814 |
P50 | author | Robert J. Wilkinson | Q30423489 |
Bianca Sossen | Q64868401 | ||
P2093 | author name string | Charlotte Schutz | |
Mpiko Ntsekhe | |||
Rachel P-J Lai | |||
Angharad G Davis | |||
Yolande Xr Harley | |||
P2860 | cites work | G protein-coupled receptors: extranuclear mediators for the non-genomic actions of steroids | Q22305605 |
Corticosteroids for managing tuberculous meningitis | Q24185853 | ||
Adjunctive steroid therapy for managing pulmonary tuberculosis | Q24188019 | ||
Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor | Q24561876 | ||
The glucocorticoid receptor inhibits NFkappaB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain | Q24600925 | ||
Tolerogenic Dendritic Cells for Regulatory T Cell Induction in Man | Q26776126 | ||
An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3 | Q28370564 | ||
Dexamethasone inhibits dendritic cell maturation by redirecting differentiation of a subset of cells | Q28378178 | ||
Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings | Q28749315 | ||
Histone acetyltransferases | Q29547823 | ||
Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF | Q29615685 | ||
Steroid receptor interactions with heat shock protein and immunophilin chaperones | Q29619628 | ||
Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase | Q30439838 | ||
Tuberculous pericarditis | Q33228602 | ||
Inflammasome Activation Underlying Central Nervous System Deterioration in HIV-Associated Tuberculosis | Q33553788 | ||
Clinical comparison of the newer anti-inflammatory corticosteroids | Q33571050 | ||
The impact of HAART initiation timing on HIV-TB co-infected patients, a retrospective cohort study | Q33758612 | ||
Diagnostic accuracy of quantitative PCR (Xpert MTB/RIF) for tuberculous pericarditis compared to adenosine deaminase and unstimulated interferon-γ in a high burden setting: a prospective study | Q33816191 | ||
Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults | Q33982474 | ||
Mechanisms of anti-inflammatory action and of immunosuppression by glucocorticoids: negative interference of activated glucocorticoid receptor with transcription factors | Q34021421 | ||
Dexamethasone and long-term outcome of tuberculous meningitis in Vietnamese adults and adolescents | Q34102881 | ||
Randomized placebo-controlled trial of prednisone for paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome | Q34130659 | ||
Free diffusion of steroid hormones across biomembranes: a simplex search with implicit solvent model calculations | Q34186724 | ||
Glucocorticoids and the Th1/Th2 balance | Q34334774 | ||
Rapid non-genomic and genomic responses to progestogens, estrogens, and glucocorticoids in the endocrine pancreatic B cell, the adipocyte and other cell types | Q34469687 | ||
Neutrophil-associated central nervous system inflammation in tuberculous meningitis immune reconstitution inflammatory syndrome | Q34488659 | ||
Timing of initiation of antiretroviral drugs during tuberculosis therapy | Q34790184 | ||
Rifampicin reduces effectiveness and bioavailability of prednisolone. | Q34991700 | ||
Prevalence, hemodynamics, and cytokine profile of effusive-constrictive pericarditis in patients with tuberculous pericardial effusion | Q35025496 | ||
Ligand-induced differentiation of glucocorticoid receptor (GR) trans-repression and transactivation: preferential targetting of NF-kappaB and lack of I-kappaB involvement. | Q35029015 | ||
A systematic review of the adjunctive use of systemic corticosteroids for pulmonary tuberculosis | Q35093493 | ||
Adjuvant corticosteroids for tuberculous pericarditis: promising, but not proven | Q35191048 | ||
Hypercytokinaemia accompanies HIV-tuberculosis immune reconstitution inflammatory syndrome | Q35622163 | ||
Corticosteroids in primary tuberculosis with bronchial obstruction | Q35625723 | ||
Corticosteroid in tuberculous meningitis | Q49127578 | ||
Prospective study of corticosteroid as an adjunct in the treatment of endobronchial tuberculosis in adults. | Q50898957 | ||
Randomized controlled trial of dexamethasone in tuberculous meningitis. | Q52026153 | ||
Controlled trial of prednisolone as adjuvant in treatment of tuberculous constrictive pericarditis in Transkei. | Q53871999 | ||
The management of tuberculous pericardial effusion: experience in 233 consecutive patients | Q56786480 | ||
Interventions for treating tuberculous pericarditis | Q56930268 | ||
Changes in cortisol metabolism following rifampicin therapy | Q70028066 | ||
Dexamethasone adjunctive treatment for tuberculous meningitis | Q70171785 | ||
Study of chemotherapy regimens of 5 and 7 months' duration and the role of corticosteroids in the treatment of sputum-positive patients with pulmonary tuberculosis in South India | Q70278777 | ||
Altered prednisolone pharmacokinetics in patients treated with rifampicin | Q71815417 | ||
Tuberculous peritonitis. An evaluation of pathogenetic mechanisms, diagnostic procedures and therapeutic measures | Q72539177 | ||
Prednisolone: a beneficial and safe adjunct to antituberculosis treatment? A randomized controlled trial | Q74642817 | ||
Corticosteroid treatment of peritoneal tuberculosis | Q74802285 | ||
PREDNISONE THERAPY AS AN ADJUNCT IN THE TREATMENT OF LYMPH NODE-BRONCHIAL TUBERCULOSIS IN CHILDHOOD. A DOUBLE-BLIND STUDY | Q76503770 | ||
Triamcinolone in primary pulmonary tuberculosis. A controlled trial | Q78947844 | ||
Immunoadjuvant prednisolone therapy for HIV-associated tuberculosis: a phase 2 clinical trial in Uganda. | Q35891202 | ||
Negative glucocorticoid receptor response elements and their role in glucocorticoid action | Q35892898 | ||
Paradoxical reaction in tuberculous meningitis: presentation, predictors and impact on prognosis | Q36058313 | ||
Corticosteroid-modulated immune activation in the tuberculosis immune reconstitution inflammatory syndrome | Q36238260 | ||
Regulatory T cells and IL-10 in allergic inflammation | Q36332180 | ||
Frequency, severity, and prediction of tuberculous meningitis immune reconstitution inflammatory syndrome | Q36517790 | ||
Tuberculous Pericarditis is Multibacillary and Bacterial Burden Drives High Mortality | Q36540925 | ||
HIV-1 tuberculosis-associated immune reconstitution inflammatory syndrome | Q36654015 | ||
Steroid Receptor Coactivator 3 Is Required for Clearing Bacteria and Repressing Inflammatory Response in Escherichia coli-Induced Septic Peritonitis | Q36808747 | ||
Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis | Q36934339 | ||
A modern approach to tuberculous pericarditis | Q36988553 | ||
Prednisolone and Mycobacterium indicus pranii in tuberculous pericarditis | Q37018268 | ||
Tuberculous pericarditis with and without HIV. | Q37994619 | ||
Corticosteroids for prevention of mortality in people with tuberculosis: a systematic review and meta-analysis | Q38078093 | ||
Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor | Q38293939 | ||
Nuclear integration of glucocorticoid receptor and nuclear factor-kappaB signaling by CREB-binding protein and steroid receptor coactivator-1. | Q38331993 | ||
Paradoxical TB-IRIS in HIV-infected adults: a systematic review and meta-analysis | Q38522810 | ||
A randomized, double-blind, placebo-controlled trial of the use of prednisolone as an adjunct to treatment in HIV-1-associated pleural tuberculosis | Q38881822 | ||
Characterization and management of paradoxical upgrading reactions in HIV-uninfected patients with lymph node tuberculosis | Q39058350 | ||
Add-on prednisolone in the management of cervical lymph node tuberculosis | Q39169490 | ||
Corticosteroids in the treatment of tuberculous pleurisy. A double-blind, placebo-controlled, randomized study | Q39463575 | ||
The clinical benefit of adjunctive dexamethasone in tuberculous meningitis is not associated with measurable attenuation of peripheral or local immune responses | Q39464569 | ||
Leukotriene A4 Hydrolase Genotype and HIV Infection Influence Intracerebral Inflammation and Survival From Tuberculous Meningitis | Q39523555 | ||
Corticosteroids in the treatment of tuberculous pleurisy. A double-blind, placebo-controlled, randomized study | Q39529717 | ||
Stimulation of preadipocyte differentiation by steroid through targeting of an HDAC1 complex | Q39756473 | ||
Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors | Q40021606 | ||
Effect of prednisolone and rifampin on isoniazid metabolism in slow and rapid inactivators of isoniazid | Q40283056 | ||
Paradoxical response during anti-tuberculosis treatment in HIV-negative patients with pulmonary tuberculosis | Q40433807 | ||
Effects of Corticosteroids on Critically Ill Pulmonary Tuberculosis Patients With Acute Respiratory Failure: A Propensity Analysis of Mortality | Q40588978 | ||
CBP (CREB binding protein) integrates NF-kappaB (nuclear factor-kappaB) and glucocorticoid receptor physical interactions and antagonism. | Q40862882 | ||
CREB-binding protein is a nuclear integrator of nuclear factor-kappaB and p53 signaling | Q40980349 | ||
Glucocorticoids promote survival of anti-inflammatory macrophages via stimulation of adenosine receptor A3. | Q42164060 | ||
Host-directed therapies against tuberculosis | Q42229497 | ||
Host genotype-specific therapies can optimize the inflammatory response to mycobacterial infections | Q42323040 | ||
Differential recruitment of tetratricorpeptide repeat domain immunophilins to the mineralocorticoid receptor influences both heat-shock protein 90-dependent retrotransport and hormone-dependent transcriptional activity. | Q42820639 | ||
Corticosteroids (dexamethasone versus intravenous methylprednisolone) in patients with tuberculous meningitis | Q43262442 | ||
Dexamethasone in tuberculous meningitis. Relationship of cerebrospinal fluid effects to therapeutic efficacy | Q43501660 | ||
Complications of HIV disease and antiretroviral therapy. | Q43549583 | ||
Effect of corticosteroids on intracranial pressure, computed tomographic findings, and clinical outcome in young children with tuberculous meningitis | Q43858728 | ||
Alteration in the levels of pyrazinamide in pleural fluid following simultaneous administration of prednisoline in patients of tubercular pleural effusion. | Q43997695 | ||
Management of tuberculous constrictive pericarditis and tuberculous pericardial effusion in Transkei: results at 10 years follow-up | Q44980912 | ||
Rationale and design of the Investigation of the Management of Pericarditis (IMPI) trial: a 2 × 2 factorial randomized double-blind multicenter trial of adjunctive prednisolone and Mycobacterium w immunotherapy in tuberculous pericarditis | Q46955156 | ||
P433 | issue | 10 | |
P921 | main subject | tuberculosis | Q12204 |
P304 | page(s) | 881-891 | |
P577 | publication date | 2018-09-06 | |
P1433 | published in | Expert Review of Respiratory Medicine | Q15754583 |
P1476 | title | Corticosteroids as an adjunct to tuberculosis therapy | |
P478 | volume | 12 |
Search more.